Evidence map›Paper›PMID 40820589›Full record

ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2025

Upadacitinib dose adjustment in moderate-to-severe atopic dermatitis: insights from a multicenter real-world study.

Flavia Manzo Margiotta, Valentina Dini, Laura Calabrese, Laura Lazzeri, Sofia Lo Conte, Manfredi Magliulo, Giulio Montesi, Leonardo Pescitelli, Nicola Milanesi, Carlo Mazzatenta and 5 more

Abstract readCase Reports
In one paragraph

Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Flavia Manzo MargiottaDepartment of Dermatology, University of Pisa, Pisa, Italy.ORCID https://orcid.org/0000-0002-9593-9357
Valentina DiniDepartment of Dermatology, University of Pisa, Pisa, Italy.
Laura CalabreseDermatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Laura LazzeriDermatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Sofia Lo ConteDermatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Manfredi MagliuloAllergological and Pediatric Dermatology Unit, Department of Health Sciences, University of Florence, Florence, Italy.
Giulio MontesiAllergological and Pediatric Dermatology Unit, Department of Health Sciences, University of Florence, Florence, Italy.
Leonardo PescitelliUnit of Dermatology, San Giuseppe Hospital, Empoli, Florence, Italy.
Nicola MilanesiDepartment of Dermatology, San Jacopo Hospital, Pistoia, Italy.
Carlo MazzatentaUnit of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy.
Emiliano AntigaDepartment of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Pietro RubegniDermatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
Massimo GolaAllergological and Pediatric Dermatology Unit, Department of Health Sciences, University of Florence, Florence, Italy.
Marco RomanelliDepartment of Dermatology, University of Pisa, Pisa, Italy.
Alessandra CartocciDermatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atopic dermatitisdoseefficacyJAK inhibitorsUpadacitinib

Identifiers

PMID40820589
PMCPMC12697318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.